Celltrion Inc., a major Korean biopharmaceutical company, has completed the acquisition of a biopharmaceutical manufacturing ...

The city state’s economy grew 5.7 per cent in the fourth quarter from a ‌year earlier, according to data from the trade ...

The Union Health Ministry is in talks with states about extending the deadline for pharmaceutical companies to meet new ...

In November 2025, US President Donald Trump announced transformative actions to lower prescription drug costs and secure the ...

Low compliance by the country’s 8,500 small and medium enterprises (MSMEs) manufacturing pharmaceuticals would raise the risk ...

The year 2025 was defined by escalating global trade tensions that fundamentally reshaped the pharmaceutical supply chain, ...

The Wegovy pill's approval signifies a shift from injectable to oral dosage forms, driven by patient preference for ...

A biopharmaceuticals company has announced a $200 million expansion in Fishers, with the expectation that in five years the ...

Drug prices have continued to rise  despite the exemption of pharmaceutical ingredients from import taxes and duties. This ...

Already boasting an outsized presence in its home country of South Korea, CDMO juggernaut Samsung Biologics is making ...

In today’s Pharmaceutical Executive Daily, the FDA approves Novo Nordisk’s oral Wegovy for chronic weight management, clears ...